Amines & Plasticizers Ltd
Incorporated in 1973, Amines & Plasticizers Ltd manufactures over 60 different varieties of organic chemicals, amines, solvents, and
fertilizers. [1]
- Market Cap ₹ 1,034 Cr.
- Current Price ₹ 188
- High / Low ₹ 255 / 127
- Stock P/E 26.9
- Book Value ₹ 52.4
- Dividend Yield 0.27 %
- ROCE 16.9 %
- ROE 13.4 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 5.25% over past five years.
- Debtor days have increased from 70.6 to 86.1 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 300 | 260 | 295 | 326 | 455 | 399 | 442 | 563 | 593 | 645 | 656 | 571 | 581 | |
| 278 | 237 | 267 | 298 | 421 | 357 | 389 | 523 | 551 | 576 | 587 | 511 | 519 | |
| Operating Profit | 22 | 23 | 28 | 28 | 34 | 42 | 53 | 40 | 42 | 69 | 68 | 60 | 62 |
| OPM % | 7% | 9% | 10% | 9% | 7% | 10% | 12% | 7% | 7% | 11% | 10% | 10% | 11% |
| 1 | 1 | 2 | 5 | 3 | 1 | 5 | 5 | 1 | 2 | 1 | 1 | 1 | |
| Interest | 10 | 8 | 6 | 7 | 8 | 9 | 10 | 9 | 10 | 13 | 10 | 5 | 5 |
| Depreciation | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 6 |
| Profit before tax | 12 | 14 | 22 | 24 | 27 | 31 | 44 | 32 | 28 | 53 | 54 | 49 | 52 |
| Tax % | 33% | 32% | 29% | 35% | 35% | 19% | 26% | 26% | 26% | 26% | 26% | 26% | |
| 8 | 10 | 15 | 15 | 17 | 25 | 33 | 24 | 21 | 39 | 40 | 36 | 39 | |
| EPS in Rs | 1.40 | 1.78 | 2.81 | 2.81 | 3.14 | 4.50 | 5.95 | 4.32 | 3.79 | 7.14 | 7.25 | 6.63 | 7.00 |
| Dividend Payout % | 7% | 11% | 11% | 11% | 10% | 7% | 7% | 9% | 13% | 7% | 7% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 5% |
| 3 Years: | -1% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 2% |
| 3 Years: | 20% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 11% |
| 3 Years: | 21% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 34 | 37 | 49 | 62 | 77 | 97 | 130 | 152 | 170 | 207 | 244 | 277 |
| 56 | 53 | 52 | 45 | 67 | 58 | 74 | 72 | 85 | 85 | 77 | 27 | |
| 41 | 39 | 46 | 67 | 88 | 65 | 91 | 75 | 74 | 83 | 68 | 92 | |
| Total Liabilities | 137 | 140 | 157 | 185 | 244 | 232 | 306 | 310 | 340 | 386 | 400 | 407 |
| 30 | 29 | 36 | 40 | 43 | 75 | 73 | 84 | 80 | 80 | 80 | 76 | |
| CWIP | 0 | 0 | 1 | 1 | 11 | 3 | 11 | 3 | 5 | 3 | 0 | 0 |
| Investments | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| 105 | 109 | 120 | 144 | 189 | 154 | 221 | 223 | 254 | 302 | 317 | 330 | |
| Total Assets | 137 | 140 | 157 | 185 | 244 | 232 | 306 | 310 | 340 | 386 | 400 | 407 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 12 | 11 | 21 | 9 | 37 | 44 | -28 | 3 | 47 | 24 | 64 | |
| -2 | -0 | -3 | -1 | -13 | -23 | -6 | -4 | -2 | -1 | -3 | -0 | |
| -2 | -12 | -8 | -16 | 10 | -23 | 6 | -13 | 1 | -15 | -20 | -58 | |
| Net Cash Flow | 0 | -0 | 0 | 4 | 5 | -8 | 44 | -44 | 1 | 30 | 1 | 5 |
| Free Cash Flow | 1 | 11 | 6 | 15 | -7 | 10 | 33 | -36 | 0 | 44 | 21 | 63 |
| CFO/OP | 26% | 67% | 62% | 99% | 49% | 107% | 103% | -50% | 21% | 87% | 55% | 126% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 54 | 55 | 49 | 62 | 63 | 73 | 66 | 75 | 56 | 69 | 86 |
| Inventory Days | 61 | 63 | 76 | 98 | 65 | 84 | 73 | 81 | 66 | 76 | 72 | 79 |
| Days Payable | 56 | 61 | 72 | 92 | 83 | 76 | 100 | 56 | 52 | 57 | 45 | 59 |
| Cash Conversion Cycle | 54 | 57 | 60 | 55 | 43 | 71 | 47 | 91 | 90 | 75 | 96 | 107 |
| Working Capital Days | 26 | 33 | 32 | 35 | 27 | 51 | 32 | 65 | 72 | 71 | 85 | 118 |
| ROCE % | 24% | 22% | 27% | 27% | 25% | 26% | 28% | 18% | 15% | 23% | 20% | 17% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Export Revenue Share % |
|
|||||||||
| Alkanolamines / Ethanolamines Revenue Share % |
||||||||||
| R&D Spend INR Crore |
||||||||||
| Morpholine & Derivatives Revenue Share % |
||||||||||
| Number of Countries Served countries |
||||||||||
| Domestic Market Share in Ethanolamines / Alkanolamines % |
||||||||||
| EO/PO Derivative Products Revenue Share % |
||||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Investor Presentation
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Submission of newspaper publication in connection with Unaudited Standalone and Consolidated Financial results for the quarter ended June 30, 2026
-
Intimation Of Record Date For Payment Of Final Dividend For The Financial Year Ended March 31, 2026 And Cut-Off Date For E-Voting In Connection With The 51St Annual General Meeting ('AGM') Of The Company
- 51st AGM on September 23, 2026; record date September 11 for Rs.0.50 final dividend.
-
Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter Ended June 30, 2026
- Board approved Q1 FY27 results, fixed 51st AGM on September 23, 2026, record date September 11.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Friday, August 14, 2026.
- Q1 FY27 results approved; AGM on September 23, 2026; record date September 11 for final dividend.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
APL was initially formed to take over India Carbons Ltd.’s project for manufacturing 3,000 tonnes of DOP plasticizers used in PVC applications. Over time, it evolved into a manufacturer and trader of organic and inorganic chemicals, including ethanolamines, morpholine, plasticizers, alkyl morpholine, gas treating solvents (like methyl diethanolamine), and morpholine oxide. Today, APL is a global supplier serving a wide range of industries.